Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to TNF Inhibitors: Two-Year Follow-up from a Phase 3 Study

被引：0
|
作者：
Orbai, Ana-Maria [1 ]
Gellett, Amanda M. [2 ]
Kerr, Lisa [2 ]
Constantin, Arnaud [3 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Hop Pierre Paul Riquet, Toulouse, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2559
引用
收藏
页数：3
相关论文
共 50 条
  • [31] PRELIMINARY RESULTS OF A TWO-YEAR FOLLOW UP OF SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Vergara-Dangond, C.
    Robustillo-Villarino, M.
    Nunez-Monje, V.
    Aguilar-Zamora, M.
    Montolio-Chiva, L.
    Valls-Pascual, E.
    Ybanez-Garcia, A.
    Martinez-Ferrer, A.
    Alegre-Sancho, J. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1316 - 1316
  • [32] Efficacy and safety of alemtuzumab in 150 patients with active relapsing-remitting MS: two-year follow-up in France
    Ayrignac, X.
    Collongues, N.
    De Seze, J.
    Vermersch, P.
    Brassat, D.
    Biotti, D.
    Carra-Dalliere, C.
    Charif, M.
    Vukusic, S.
    Durand-Dubief, F.
    Edan, G.
    Lepage, E.
    Deburghgraeve, V.
    Maillart, E.
    Papeix, C.
    Alla, P.
    Berger, E.
    Bourre, B.
    Casez, O.
    Pittion, S.
    Debouverie, M.
    Derache, N.
    Defer, G.
    Gout, O.
    Deschamps, R.
    Tourbah, A.
    Zagnoli, F.
    Ruet, A.
    Ouallet, J. C.
    Brochet, B.
    Manchon, E.
    Moreau, T.
    Fromont, A.
    Clavelou, P.
    Guennoc, A-M.
    Camdessanche, J. P.
    Carpentier, A.
    Coman, I.
    Audoin, B.
    Pelletier, J.
    Magy, L.
    Wiertlewski, S.
    Laplaud, D.
    Ciron, J.
    De Broucker, T.
    Frenay, C. Lebrun
    Cohen, M.
    Labauge, P.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 604 - 605
  • [33] Outcome of inflammatory bowel disease patients treated with TNF-α inhibitors: two-year follow-up
    Lehtola, Erika
    Haapamaki, Johanna
    Farkkila, Martti A.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (12) : 1476 - 1481
  • [34] Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: Findings of the infliximab multinational psoriatic arthritis controlled trial (IMPACT)
    Antoni, Christian E.
    Kavanaugh, Arthur
    van der Heijde, Desiree
    Beutler, Anna
    Keenan, Gregory
    Zhou, Bie
    Kirkham, Bruce
    Tutuncu, Zuhre
    Burmester, Gerd R.
    Schneider, Udo
    Furst, Daniel E.
    Molitor, Jerry
    Keystone, Edward
    Gladman, Dafna D.
    Manger, Bernhard
    Wassenberg, Siegfried
    Weier, Ralf
    Wallace, Daniel J.
    Weisman, Michael H.
    Kalden, Joachim R.
    Smolen, Josef S.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (05) : 869 - 876
  • [35] Bimekizumab Treatment in Patients with Active PsA and Prior Inadequate Response to TNF Inhibitors: Sustained Efficacy and Safety Results from a Phase 3 Study and Its Open-Label Extension up to 1 Year
    Coates, Laura
    Landewe, Robert B. M.
    McInnes, Iain
    Mease, Philip J.
    Ritchlin, Christopher T.
    Tanaka, Yoshiya
    Asahina, Akihiko
    Behrens, Frank
    Gladman, Dafna
    Gossec, Laure
    Gottlieb, Alice B.
    Warren, Richard B.
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Merola, Joseph
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4401 - 4404
  • [36] 52-Week Efficacy and Safety Results from SPIRIT-P1: A Phase 3 Study of Ixekizumab in Patients with Active Psoriatic Arthritis
    Mease, Philip
    Okada, Masan
    Kishimoto, Mitsumasa
    Shuler, Catherine
    Carlier, Hilde
    Lin, Chen-Yen
    Mou, Jiani
    Moriarty, Susan
    Lee, Chin
    Gladman, Dafna
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 925 - 925
  • [37] Ixekizumab Treatment Results in Rapid and Sustained Improvements in the Disease Activity Index for Psoriatic Arthritis (DAPSA) in Patients Naive to Biologic DMARDs or with Previous Inadequate Response to TNF Inhibitors
    Sunkureddi, Prashanth
    Zhu, Baojin
    Ogdie, Alexis
    Spraberry, Aubrey
    Lisse, Jeffrey
    Lin, Chen-Yen
    Shrom, David
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [38] A two-year follow-up study in Korean patients with fibromyalgia
    Lee, SS
    Yoon, HJ
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S310 - S311
  • [39] SAFETY AND EFFICACY OF ETANERCEPT IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WITH PERIPHERAL INVOLVEMENT IN BELGIUM: 66 MONTHS FOLLOW-UP
    de Vlam, K.
    Boone, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 968 - 968
  • [40] Comparative efficacy and safety of secukinumab, ixekizumab, and tofacitinib in patients with active psoriatic arthritis showing insufficient response to tumor necrosis factor inhibitors
    Song, Gwan Gyu
    Lee, Young Ho
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (07) : 511 - 518
12345